4 drug(s) with this reaction
526 total reports
Atrial Fibrillation has been reported as an adverse reaction across 4 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 526 adverse event reports mention atrial fibrillation in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with atrial fibrillation, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have atrial fibrillation listed in their FDA adverse event reports, sorted by report count:
In addition to atrial fibrillation, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
4 drug(s) manufactured by Chattem Inc have atrial fibrillation listed in their FDA adverse event reports: LIDOCAINE, MENTHOL, LIDOCAINE HCL, SELENIUM SULFIDE, TROLAMINE SALICYLATE.
There are a combined 526 reports of atrial fibrillation across 4 Chattem Inc drug(s) in the FDA adverse event database.